Wednesday, July 20, 2011
NeoStem Inc., of New York, is bringing in gross proceeds of about $16.5 million in a public offering of 13.75 million units each consisting of one share of common stock and a warrant to purchase 0.75 of a share priced at $1.20 per unit. Funds will be used for working capital purposes, including R&D work on cell therapeutic product candidates, expansion of business units and other general corporate purposes.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.